New Risk • Jun 26
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Market cap is less than US$10m (₩14.9b market cap, or US$9.67m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change). Board Change • Apr 30
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Tillkännagivande • Feb 13
IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026 IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea New Risk • Aug 26
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩20.6b market cap, or US$14.8m). New Risk • Aug 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₩19.3b market cap, or US$14.0m). Tillkännagivande • Aug 11
IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion. IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 5,652,655
Price\Range: KRW 858
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 647,345
Price\Range: KRW 858
Transaction Features: Rights Offering Board Change • May 26
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Tillkännagivande • Apr 26
IMAGIS Co., Ltd. announced that it has received KRW 999.999675 million in funding On April 25, 2025, IMAGIS Co., Ltd., closed the transaction. Tillkännagivande • Apr 17
IMAGIS Co., Ltd. announced that it expects to receive KRW 999.999675 million in funding IMAGIS Co., Ltd. announces private placement to issue 687,285 Common Shares at a price of KRW 1,455 for gross proceeds of KRW 999,999,675 on April 17, 2025. Expected date of the closing is April 25, 2025. Tillkännagivande • Feb 27
815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul. 815 Life & Health Co., Ltd. and others agreed to acquire 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul for KRW 22.0 billion on December 12, 2024. A cash consideration valued at KRW 5432 per share will be paid by 815 Life & Health Co., Ltd. As part of consideration, an KRW 22 billion value is paid towards common equity of IMAGIS Co., Ltd.
The expected completion of the transaction is March 25, 2025. As of January 24, 2025, the transaction closing date is expected on February 25, 2025.
815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul on February 26, 2025. The cancellation occurred due to non-payment of the balance of the transfer company's stock sale. Tillkännagivande • Feb 12
IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025 IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea New Risk • Nov 04
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩52.8b market cap, or US$38.5m). New Risk • Sep 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩39.6b market cap, or US$29.8m). New Risk • Aug 31
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩34.7b market cap, or US$26.0m). New Risk • Apr 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩48.7b market cap, or US$35.3m). New Risk • Jul 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩41.5b market cap, or US$31.9m). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Tillkännagivande • Feb 09
IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021 IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time. Is New 90 Day High Low • Jan 29
New 90-day low: ₩2,210 The company is down 17% from its price of ₩2,650 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 46% over the same period. Is New 90 Day High Low • Nov 17
New 90-day low: ₩2,485 The company is down 14% from its price of ₩2,880 on 19 August 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 19% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: ₩2,650 The company is down 16% from its price of ₩3,145 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is down 3.0% over the same period. 
